Effect of Systemic Creatine Monohydrate Supplementation on Denervated Muscle During Reinnervation: Experimental Study in the Rat

ABSTRACT

The purpose of this experimental study was to evaluate possible upgrading effects of systemic creatine monohydrate administration on the reinnervation of denervated muscle. At the same time, the protective effect of the agent on denervated muscle until ultimate reinnervation after nerve repair was quantified. The functional outcome of muscle reinnervation after creatine monohydrate application was compared with a control group. Forty adult Wistar rats weighing 180 to 220 g were used. The right sciatic nerve was dissected, exposed, and cut at the level of the midthigh in all rats. The experimental design consisted of two groups: experimental (animals were fed creatine monohydrate) and control (gavage feeding was provided by saline). Both groups were divided into two subgroups: subgroups A and B for the experimental group, and subgroups C and D for the control group. In subgroups A and C, the nerves were repaired with four 10-0 epineurial stitches. In subgroups B and D, both the proximal and distal ends of the nerves were ligated and no neural anastomosis was performed. In the experimental groups (subgroups A and B), the rats were fed by daily supplementation of oral creatine monohydrate, 300 mg/kg body weight. In the controls (subgroups C and D), oral supplementation was provided by saline.

Functional recovery was evaluated using walking track analysis, pinching test, and limb circumference and toe contracture measurements at the end of 6 months, after which the rats were sacrificed and nerve specimens from both ends of the repair sites and the whole gastrocnemius muscle were obtained to document the results of the histomorphometric and histochemical studies, including light microscopic examinations and muscle weight measurements. The mean functional recovery values in subgroups A, B, C, and D were 91 percent, 80 percent, 87 percent, and 59 percent, respectively. Functional recovery improved significantly in the experimental groups (in both the surgically repaired and unrepaired subgroups), compared with the control groups (p < 0.05). The pinching test revealed a statistically significant difference in nerve conduction between the experimental and control groups (p < 0.05). The limb circumference ratio of the surgically treated side to the untouched side in subgroups A, B, C, and D were noted as 0.95, 0.89, 0.91, and 0.87, respectively, and the difference between the experimental and the control groups was statistically significant(p < 0.05). The differences between subgroups A and B, C and D, A and C, and B and D were also significant. The surgically repaired and creatine-supplemented subgroups demonstrated the best results in toe contracture index. The muscle weight measurement results were concordant with the results of the limb circumference ratio. In both surgically repaired subgroups (subgroups A and C), there were qualitatively significant amounts of myelinated fibers in the nerve distal to the anastomotic site; there were no myelinated fibers in the distal stumps of subgroups B and D. Histochemical analyses of the contents of the muscle fiber types also revealed no significant difference.

Overall, the results showed the useful effect of oral creatine supplementation on both surgically repaired and unrepaired nerve injuries. The best results were obtained from surgically repaired nerve injuries and also from the systemic creatine-supplemented subgroups. This study confirms that systemic administration of creatine monohydrate has a protective and upgrading effect on the functional properties of denervated muscle, especially in surgically reinnervated subjects.

Creatine monohydrate - denervated muscle - surgical reinnervation - rat model

REFERENCES

• 1 Drago J, Kilpatrick T J, Koblar S A, Talman P S. Growth factors: potential therapeutic applications in neurology.  J Neurol Neurosurg Psychiatry. 1994;  57 1445-1450
• 2 Levi-Montalcini R. The nerve growth factor 35 years later.  Science. 1987;  237 1154-1162
• 3 Whitworth I H, Brown R A, Dore C J et al.. Nerve growth factor enhances nerve regeneration through fibronectin grafts.  J Hand Surg. 1996;  21 514-522
• 4 Young J C, Young R E. The effect of creatine supplementation on glucose uptake in rat skeletal muscle.  Life Sciences. 2002;  71 1731-1737
• 5 Wiedermann D, Schneider J, Fromme A et al.. Creatine loading and resting skeletal muscle phosphocreatine flux: a saturation-transfer NMR study.  MAGMA. 2001;  13 118-126
• 6 Van Leemputte M, Vandenberghe K, Hespel P. Shortening of muscle relaxation time after creatine loading.  J Appl Physiol. 1999;  86 840-844
• 7 Eijnde B O, Urso B, Richter E A et al.. Effect of oral creatine supplementation on human muscle GLUT4 protein content after immobilization.  Diabetes. 2001;  50 18-23
• 8 Parise G, Mihic S, MacLennan D et al.. Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis.  J Appl Physiol. 2001;  91 1041-1047
• 9 Persky A M, Brazeau G A. Clinical pharmacology of the dietary supplement creatine monohydrate.  Pharmacol Rev. 2001;  53 161-176
• 10 Hespel P, Eijnde B O, Leemputte M V et al.. Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans.  J Physiol. 2001;  536 625-633
• 11 Özkan Ö, Şafak T, Vargel I et al.. Reinnervation of denervated muscle in a split-nerve transfer model.  Ann Plast Surg. 2002;  49 532-540
• 12 Paydarfar J A, Paniello R C. Functional study of four neurotoxins as inhibitors of post-traumatic nerve regeneration.  Laryngoscope. 2001;  111 844-850
• 13 Tetik C, Ozer K, Ayhan S et al.. Conventional versus epineurial sleeve neurorrhaphy technique: functional and histomorphometric analysis.  Ann Plast Surg. 2002;  49 397-403
• 14 Crumley R L, Horn K, Clendenning D. Laryngeal reinnervation using the split-phrenic nerve-graft procedure.  Otolaryngol Head Neck Surg. 1980;  88 159-164
• 15 Tarnopolsky M, Martin J. Creatine monohydrate increases strength in patients with neuromuscular disease.  Neurology. 1999;  52 854-857
• 16 Walter M C, Lochmüller H, Reilich P et al.. Creatine monohydrate in muscular dystrophies: a double-blind, placebo-controlled clinical study.  Neurology. 2000;  54 1848-1850
• 17 Doherty T J, Lougheed K, Markez J, Tarnopolsky M A. Creatine monohydrate does not increase strength in patients with hereditary neuropathy.  Neurology. 2001;  57 559-560
• 18 Williams M H, Branch J D. Creatine supplementation and exercise performance: an update.  J Am Coll Nutr. 1998;  17 216-234
• 19 Willer B, Stucki G, Hoppeler H et al.. Effects of creatine supplementation on muscle weakness in patients with rheumatoid arthritis.  Rheumatology. 2000;  39 293-298
• 20 Klopstock T, Querner V, Schmidt F et al.. A placebo-controlled crossover trial of creatine in mitochondrial diseases.  Neurology. 2000;  55 1748-1751
• 21 Walter M C, Lochmüller H, Reilich P. Creatine monohydrate in muscular dystrophies: a double-blind, placebo-controlled clinical study.  Neurology. 2000;  54 1848-1850
• 22 Stout J, Eckerson J, Ebersole K et al.. Effect of creatine loading on neuromuscular fatigue threshold.  J Appl Physiol. 2000;  88 109-112
• 23 Tarnopolsky M A, Beal F. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders.  Ann Neurol. 2001;  49 561-574
• 24 Jacobs P L, Mahoney E T, Cohn K A, Sheradsky L F, Green B A. Oral creatine supplementation enhances upper extremity work capacity in persons with cervical-level spinal cord injury.  Arc Phys Med Rehabil. 2002;  83 19-23